| MR编号 | NL/H/3938/001 |
|---|
| 药品名称 | Bortezomib CF 2,5 mg/ml, solution for injection |
|---|
| 活性成分 | |
|---|
| 剂型 | Solution for injection |
|---|
| 上市许可持有人 | Centrafarm B.V.
Breda
4814 NE
Nederland |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Bortezomib CF 2,5 mg/ml, oplossing voor injectie |
|---|
| 互认成员国 - 产品名称 | - Estonia (EE)
- Latvia (LV)
Bortezomib Stada 2,5 mg/ml šķīdums injekcijām - Italy (IT)
- Finland (FI)
- Sweden (SE)
- Spain (ES)
- France (FR)
- Austria (AT)
Bortezomib STADA 2,5 mg/ml Injektionslösung - Ireland (IE)
- Luxembourg (LU)
- Belgium (BE)
Bortezomib EG 2,5 mg/ml oplossing voor injectie - Denmark (DK)
Bortezomib Stada - Germany (DE)
- Malta (MT)
Bortezomib Clonmel 2.5mg/ml Solution for Injection - Greece (GR)
- Cyprus (CY)
Bortezomib/STADA - Norway (NO)
- Romania (RO)
Bortezomib Stada 2,5 mg/ml soluţie injectabilă - Hungary (HU)
BORTEZOMIB STADA 2,5 mg/ml oldatos injekció - United Kingdom (Northern Ireland) (XI)
- Portugal (PT)
- Iceland (IS)
- Lithuania (LT)
Bortezomib STADA 2,5 mg/ml injekcinis tirpalas
|
|---|
| 许可日期 | 2018/01/25 |
|---|
| 最近更新日期 | 2025/08/28 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|